Press Releases Bayer AG

Equities

BAYN

DE000BAY0017

Market Closed - Xetra Other stock markets 11:36:14 2024-06-11 am EDT			After market 02:08:02 pm
27.08 ^EUR	-1.44%		27.12	+0.16%

03:21pm	Dpa-AFX Overview: COMPANIES as of 11/06/2024 - 15:15	DP
01:22pm	Bayer: decision in China for lung cancer	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 23	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 22	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 21	EQ
Bayer : Q1 Media Update	May. 14	PU
Bayer : First-quarter performance as expected	May. 14	PU
Bayer : Debt Investor Information FY 2023 / Q1 2024 (DE)	May. 13	PU
Bayer : Debt Investor Information FY 2023 Q1 204	May. 13	PU
Bayer : Quarterly Statement First Quarter 2024	May. 13	PU
Bayer : Address by Bill Anderson	Apr. 26	PU
Bayer : Address by Bill Anderson	Apr. 22	PU
Bayer : Explanations to the Supervisory Board Report - Prof. Dr. Norbert Winkeljohann	Apr. 22	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 17	EQ
Bayer - AskBio Names Mansuo Shannon Chief Scientific Officer	Apr. 10	AQ
Bayer and Vividion Therapeutics to highlight advancing oncology portfolio at AACR 2024 Annual Meeting	Apr. 04	AQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 03	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Mar. 27	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Mar. 22	EQ
Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth	Mar. 21	AQ
Bayer - Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer's elinzanetant	Mar. 20	AQ
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing - Evogene	Mar. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BAYER : As soft as anticipated

May 14, 2024 at 02:12 pm EDT

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am EST